These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20561650

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Aspecific transfer factor in children with Hodgkin's disease.
    Pasino M, Vadalà CR, Tonini GP, Comelli A, Perutelli P.
    Boll Ist Sieroter Milan; 1976; 55(2):168-73. PubMed ID: 1088071
    [Abstract] [Full Text] [Related]

  • 23. The role of immunology in the diagnosis and treatment of cancer.
    Humphrey LJ, Pierce GE.
    Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients.
    Lamoureux G, Cosgrove J, Duquette P, Lapierre Y, Jolicoeur R, Vanderland F.
    Clin Exp Immunol; 1981 Mar; 43(3):557-64. PubMed ID: 7026094
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Transfer Factor: Myths and Facts.
    Macias AE, Guaní-Guerra E.
    Arch Med Res; 2020 Oct; 51(7):613-622. PubMed ID: 32654883
    [Abstract] [Full Text] [Related]

  • 31. Interstitial transfer factor as adjuvant immunotherapy for experimental glioma.
    Pineda B, Estrada-Parra S, Pedraza-Medina B, Rodriguez-Ropon A, Pérez R, Arrieta O.
    J Exp Clin Cancer Res; 2005 Dec; 24(4):575-83. PubMed ID: 16471320
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
    Losy J.
    Neurol Neurochir Pol; 2000 Dec; 34(3 Suppl):63-9. PubMed ID: 10983302
    [Abstract] [Full Text] [Related]

  • 34. Improving combination trials for multiple sclerosis.
    Trojano M.
    Lancet Neurol; 2010 Jul; 9(7):646-7. PubMed ID: 20542737
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cellular immunity in acne vulgaris during transfer factor treatment.
    Ashorn R, Uotila A, Kuokkanen K, Räsänen L, Karhumäki E, Krohn K.
    Ann Clin Res; 1985 Jul; 17(4):152-5. PubMed ID: 2934019
    [Abstract] [Full Text] [Related]

  • 37. Transfer factor and its signification for practice.
    Mrázová A, Mráz J.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993 Jul; 36(3):117-37. PubMed ID: 8159909
    [Abstract] [Full Text] [Related]

  • 38. [Concepts of stimulating immunotherapy].
    Aiuti F, Montella F.
    Minerva Med; 1982 Apr 07; 73(15):895-8. PubMed ID: 6176915
    [No Abstract] [Full Text] [Related]

  • 39. Effect of long-term therapy with transfer factor in rheumatoid arthritis.
    Georgescu C.
    Med Interne; 1985 Apr 07; 23(2):135-40. PubMed ID: 4023587
    [Abstract] [Full Text] [Related]

  • 40. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K, Grunnet E, Zachariae H.
    Acta Derm Venereol; 1982 Apr 07; 62(1):47-53. PubMed ID: 6175137
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.